0001683168-23-008135.txt : 20231114 0001683168-23-008135.hdr.sgml : 20231114 20231114163053 ACCESSION NUMBER: 0001683168-23-008135 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20231107 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avid Bioservices, Inc. CENTRAL INDEX KEY: 0000704562 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953698422 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32839 FILM NUMBER: 231407011 BUSINESS ADDRESS: STREET 1: 14191 MYFORD ROAD CITY: TUSTIN STATE: CA ZIP: 92780 BUSINESS PHONE: 714.508.6100 MAIL ADDRESS: STREET 1: 14191 MYFORD ROAD CITY: TUSTIN STATE: CA ZIP: 92780 FORMER COMPANY: FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: TECHNICLONE CORP/DE/ DATE OF NAME CHANGE: 19970924 FORMER COMPANY: FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP DATE OF NAME CHANGE: 19920703 8-K 1 avid_8k.htm FORM 8-K
false 0000704562 0000704562 2023-11-07 2023-11-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 7, 2023

 

 

 

AVID BIOSERVICES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware 001-32839 95-3698422
(State of other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

 

14191 Myford Road, Tustin, California 92780

(Address of Principal Executive Offices)

 

Registrant’s telephone number, including area code: (714) 508-6100

 

__________________________________

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class Trading Symbol Name of each exchange on which registered
Common Stock, $0.001 par value per share CDMO The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

   Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

   

 

 

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

 

Amendment to Deferred Compensation Plan

 

On November 7, 2023, the Board of Directors (the “Board”) of Avid Bioservices, Inc. (the “Company”) approved and adopted an amendment (the “First Amendment”) to the Avid Bioservices, Inc. Deferred Compensation Plan dated July 7, 2023 (the “Plan”). The First Amendment makes certain modifications to the Plan in order to clarify that a participant who elects to defer equity awards, and therefore receives an interest in the Company Stock Fund (as defined in the Plan), will not be permitted to diversify such interest by transferring amounts out of the Company Stock Fund. In addition, the First Amendment makes certain modifications to clarify that distributions to a participant under the Plan shall be made in a lump sum consisting of cash and/or equity depending upon the composition of such participant’s deferral account at the time of such distribution.

 

The foregoing description is qualified in its entirety by reference to the First Amendment, a copy of which is filed as exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(d) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:

 

Exhibit Number   Description
     
10.1

First Amendment to Avid Bioservices, Inc. Deferred Compensation Plan

104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

 

 

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AVID BIOSERVICES, INC.  
       
       
Date: November 14, 2023 By: /s/ Daniel R. Hart  
    Daniel R. Hart  
    Chief Financial Officer  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 

 

EX-10.1 2 avid_ex1001.htm FIRST AMENDMENT TO AVID BIOSERVICES, INC. DEFERRED COMPENSATION PLAN

Exhibit 10.1

 

 

First Amendment to the

Avid Bioservices, Inc. Deferred Compensation Plan

 

Effective as of July 7, 2023, Avid Bioservices, Inc., a Delaware corporation (the “Company”), established the Avid Bioservices, Inc. Deferred Compensation Plan (the “Plan”). By adoption of this instrument, the Company now desires to amend the Plan to make the clarifying and administrative changes set forth below.

 

1. This Amendment shall be effective as November 7, 2023.

 

2. Section 6.2(d)(2) of the Plan is hereby amended and restated in its entirety to read as follows:

 

(2) Amounts cannot be transferred out of the Company Stock Fund.

 

3. Section 6.2(d)(3) of the Plan is hereby amended and restated in its entirety to read as follows:

 

(3) Any election by a Participant to hypothetically invest any amount in the Company Stock Fund shall be subject to all applicable securities law requirements, including but not limited to Rule 16b-3 of the Securities Exchange Act of 1934, as amended, promulgated by the Securities Exchange Commission. To the extent that any election violates any securities law, rule or regulation, or rule or regulation of the Company including, without limitation, the Company’s blackout policies, the election shall be void.

 

4. Section 7.2(e) of the Plan is hereby amended and restated in its entirety to read as follows:

 

(e) Unforeseeable Emergency. A Participant may withdraw up to 100% of his or her Accounts in the event that an Unforeseeable Emergency occurs prior to the day on which his or her benefit payments begin pursuant to Section 7.3 (Timing and Form of Distribution). The withdrawal may not exceed the amount reasonably necessary to satisfy the Participant’s Unforeseeable Emergency (including the amount of any federal, state, or local income taxes or penalties reasonably anticipated to result from the withdrawal), as determined in compliance with Treasury Regulation Section 1.409A-3(i)(3)(ii). A Participant who wishes to withdraw amounts pursuant to this Section 7.2(e) must submit, on a form provided by the Plan Administrator, a written request to the Plan Administrator that: (i) describes the Unforeseeable Emergency for which the withdrawal is being requested; (ii) describes the amount needed to satisfy the Unforeseeable Emergency, which amount may include any federal, state, or local income taxes or penalties reasonably anticipated to result from the withdrawal; (iii) includes a representation that the Unforeseeable Emergency cannot reasonably be relieved through (1) reimbursement or compensation by insurance or otherwise; (2) by liquidation of the Participant’s assets to the extent the liquidation of such assets would not itself cause a severe financial hardship; or (3) by cessation of Deferrals pursuant to this Plan; (iv) identifies the date on which the withdrawal is being requested; and (v) provides any other information the Plan Administrator deems necessary. The Participant must submit the written request at least 30 days prior to the date on which the Participant is requesting the withdrawal. If the Plan Administrator, in its discretion, grants the Participant’s request for a withdrawal pursuant to this Section 7.2(e), the Participant will receive a distribution in a single lump sum payment within 60 days following receipt of the Participant’s written request. The decision to grant a Participant’s request for a withdrawal under this Section 7.2(e) shall be left to the absolute discretion of the Plan Administrator and the Plan Administrator may deny such request for any or no reason even if an Unforeseeable Emergency clearly exists.

 

5. Section 7.3(a)(2) of the Plan is hereby amended and restated in its entirety to read as follows:

 

(2) If the Participant incurs a Separation from Service at or after age 60, or prior to age 60 with more than five (5) Years of Service, then all amounts distributable on account of Separation from Service shall be made, consistent with the Participant’s Deferral Agreement elections, either in a single lump sum payment or in annual installments over a one (1) to 10 year period. In the event amounts are distributed in a single lump sum, payment will be made within 60 days following the Separation from Service. In the event amounts are distributed in installments, the first installment shall be paid within 60 days following the Separation from Service and each subsequent installment shall be paid within the first 60 days of the applicable anniversary of the first installment payment date. Installment distributions shall be subject to such uniform rules and procedures as may be adopted by the Plan Administrator from time to time. Each installment payment is to be treated as a separate payment pursuant to Treasury Regulation Section 1.409A-2(b)(2)(iii).

 

 

 

 1 

 

 

6. Section 7.3(b) of the Plan is hereby amended and restated in its entirety to read as follows:

 

(b) DISABILITY. All amounts distributable on account of a Participant’s Disability shall be made in a single lump sum payment within 60 days following the date of the Participant’s Disability. For the avoidance of doubt, if a Participant becomes Disabled after installment payments have commenced, all amounts due to the Participant and/or Beneficiary shall be accelerated and paid in a single lump sum payment within 60 days following the date of the Participant’s Disability.

 

7. Section 7.3(c) of the Plan is hereby amended and restated in its entirety to read as follows:

 

(c) Death. All amounts distributable on account of a Participant’s death shall be made in a single lump sum payment within 60 days following the date of the Participant’s death. For the avoidance of doubt, if a Participant dies after installment payments have commenced, all amounts due to the Participant and/or Beneficiary shall be accelerated and paid in a single lump sum payment within 60 days following the date of the Participant’s death.

 

8. Section 7.3(d) of the Plan is hereby amended and restated in its entirety to read as follows:

 

(d) SPECIFIED DATES. All amounts distributable on account of the Participant’s election to receive a distribution of all or a designated portion of his accounts on a specified date must be deferred for at least three (3) years. Such amounts shall be paid, consistent with the Participant’s Deferral Agreement elections, either in a single lump sum payment or in annual installments over a one (1) to five (5) year period. In the event amounts are distributed in a single lump sum, payment will be made within 60 days following the specified date selected by the Participant in his or her Distribution Election Form. In the event amounts are distributed in installments, the first installment shall be paid within 60 days following the specified date selected by the Participant in his or her Distribution Election Form and each subsequent installment shall be paid within the first 60 days of the applicable anniversary of the first installment payment date. Installment distributions shall be subject to such uniform rules and procedures as may be adopted by the Plan Administrator from time to time. Each installment payment is to be treated as a separate payment pursuant to Treasury Regulation Section 1.409A-2(b)(2)(iii).

 

9. Section 7.3(e) of the Plan is hereby amended and restated in its entirety to read as follows:

 

(e) Election. The form of distribution for amounts distributable on account of Separation from Service or upon a specified date or dates shall be designated by the Participant in a Distribution Election Form (which may be contained in and be a part of a Deferral Agreement). The Distribution Election Form must comply with provisions of Section 3.4 (Deferral Agreement). If a Participant fails to return a completed Distribution Election Form for a Plan Year subsequent to completing his or her initial Distribution Election Form, such Participant shall not be deemed to have continued the same election from the prior Plan Year. Once elected, a Participant may change his or her prior distribution election by filing a new Distribution Election Form in accordance with Section 7.3(f) (Timing and Form of Distribution - Changes in Time and Form of Distribution). If a revised Distribution Election Form is not honored because it was not timely filed, distributions shall be made pursuant to the most recent valid Distribution Election Form filed by the Participant. If no valid Distribution Election Form exists, the Participant’s Account will be distributed in a single lump payment.

 

10. Section 7.7 of the Plan is hereby amended and restated in its entirety to read as follows:

 

7.7 SMALL ACCOUNT BALANCES. Notwithstanding any provision in this Plan to the contrary, in the event that the amount credited to the Participant’s Accounts as of the date his or her payments commence is less than the applicable dollar amount under Section 402(g)(1)(B) of the Code, the Plan Administrator may elect to pay the amount credited to the Participant’s Accounts in a lump sum payment. The Plan Administrator must inform the Participant in writing on or before the date of a distribution pursuant to this Section that the Plan Administrator has elected to distribute the Participant’s Accounts pursuant to this Section. Any payment to a Participant pursuant to this Section must represent the complete liquidation of the Participant’s interest in the Plan.

 

11. This Amendment shall only amend the provisions of the Plan referred to above, and those provisions not amended hereby shall be considered in full force and effect. Notwithstanding the foregoing, this Amendment shall supersede the provisions of the Plan to the extent those provisions are inconsistent with the provisions and intent of this Amendment.

 

 

 2 

 

 

IN WITNESS WHEREOF, the Company has caused this Amendment to be executed as of this 14th day of November, 2023.

 

  Avid Bioservices, Inc.
   
   
  By: /s/ Nicholas S. Green
   
   
  Its: President and Chief Executive Officer
   
   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 

EX-101.SCH 3 cdmo-20231107.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 cdmo-20231107_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 cdmo-20231107_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Nov. 07, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 07, 2023
Entity File Number 001-32839
Entity Registrant Name AVID BIOSERVICES, INC.
Entity Central Index Key 0000704562
Entity Tax Identification Number 95-3698422
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 14191 Myford Road
Entity Address, City or Town Tustin
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92780
City Area Code (714)
Local Phone Number 508-6100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol CDMO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 7 avid_8k_htm.xml IDEA: XBRL DOCUMENT 0000704562 2023-11-07 2023-11-07 iso4217:USD shares iso4217:USD shares false 0000704562 8-K 2023-11-07 AVID BIOSERVICES, INC. DE 001-32839 95-3698422 14191 Myford Road Tustin CA 92780 (714) 508-6100 false false false false Common Stock, $0.001 par value per share CDMO NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://avidbio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports avid_8k.htm cdmo-20231107.xsd cdmo-20231107_lab.xml cdmo-20231107_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "avid_8k.htm": { "nsprefix": "CDMO", "nsuri": "http://avidbio.com/20231107", "dts": { "inline": { "local": [ "avid_8k.htm" ] }, "schema": { "local": [ "cdmo-20231107.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "cdmo-20231107_lab.xml" ] }, "presentationLink": { "local": [ "cdmo-20231107_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://avidbio.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-11-07", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "avid_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-11-07", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "avid_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://avidbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001683168-23-008135-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-23-008135-xbrl.zip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end